Vaccine developer and provides laboratory diagnostic services

The BIKEN Group is a specialized bio-pharmaceutical organization focused on the development and manufacturing of vaccines. Their product line includes a variety of inactivated vaccines and toxoids, such as the Influenza HA vaccine, Japanese Encephalitis vaccine, and combined vaccines for Diphtheria, Pertussis, Tetanus, and Inactivated Polio. Notably, BIKEN emphasizes that all their products are developed and manufactured in-house, ensuring quality control and innovation in their vaccine offerings. They also produce live attenuated vaccines, including those for Varicella and Measles-Rubella, as well as diagnostic antigens.

In recent developments, the BIKEN Group has engaged in strategic partnerships to advance vaccine technology, such as the agreement with VLPT Japan and Denka to develop a self-amplifying "replicon" RNA influenza vaccine. This collaboration highlights BIKEN's commitment to leveraging cutting-edge scientific advancements to enhance public health. Additionally, the company has received marketing authorization for various combined vaccines, demonstrating their active role in addressing infectious diseases through innovative vaccine solutions.

Japan

The Biken Group is a Specialty Bio-Pharmaceutical Organization that contributes to public health through developing, manufacturing and supplying many of Japan's first vaccines, and also providing laboratory diagnostic services.

BIKEN Group

Company Details